Why medication in involuntary treatment may be less effective: The placebo/nocebo effect

Medical Hypotheses

Volumn 77, Issue 6, 2011, Pages 993-995

  Meynen, Gerben ^a   Swaab, Dick F ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ARTICLE; CONTROLLED STUDY; DEPRESSION; HUMAN; INVOLUNTARY COMMITMENT; PLACEBO EFFECT; PSYCHIATRY; RANDOMIZED CONTROLLED TRIAL; VOLUNTARY PROGRAM;

COERCION; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PLACEBO EFFECT; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 80755140584     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.08.029     Document Type: Article

References (20)

1. Prinsen E.J., Van Delden J.J. Can we justify eliminating coercive measures in psychiatry?. J Med Ethics 2009, 35(1):69-73.
2. Sheehan K.A. Compulsory treatment in psychiatry. Curr Opin Psychiatry 2009, 22(6):582-586.
3. Cherry M.J. Non-consensual treatment is (nearly always) morally impermissible. J Law Med Ethics 2010, 38(4):789-798.
4. Bergk J., Einsiedler B., Steinert T. Feasibility of randomized controlled trials on seclusion and mechanical restraint. Clin Trials 2008, 5(4):356-363.
5. Enck P., Benedetti F., Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008, 59(2):195-206.
6. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med 2010, 16(11):1277-1283.
7. Miller F.G., Wendler D. Placebo research and the spirit of informed consent. Psychosom Med 2005, 67(4):678. [author reply 678].
8. Beauregard M. Effect of mind on brain activity: evidence from neuroimaging studies of psychotherapy and placebo effect. Nord J Psychiatry 2009, 63(1):5-16.
9. Fournier J.C., Derubeis R.J., Hollon S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010, 303(1):47-53.
10. Miller F. The debate over placebo-controlled trials. PLoS Med 2005, 2(6):e157. [author reply e187].
11. Rief W., Nestoriuc Y., Weiss S., Welzel E., Barsky A.J., Hofmann S.G. Meta-analysis of the placebo response in antidepressant trials. J Affect Disord 2009, 118(1-3):1-8.
12. Mayberg H.S., Silva J.A., Brannan S.K., Tekell J.L., Mahurin R.K., Mcginnis S., et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002, 159(5):728-737.
13. Bingel U., Colloca L., Vase L. Mechanisms and clinical implications of the placebo effect: is there a potential for the elderly? A mini-review. Gerontology 2011, 57:354-363.
14. Miller F.G., Wendler D., Swartzman L.C. Deception in research on the placebo effect. PLoS Med 2005, 2(9):e262.
15. Waber R.L., Shiv B., Carmon Z., Ariely D. Commercial features of placebo and therapeutic efficacy. JAMA 2008, 299(9):1016-1017.
16. Wager T.D., Atlas L.Y., Leotti L.A., Rilling J.K. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J Neurosci 2011, 31(2):439-452.
17. Benedetti F., Arduino C., Costa S., Vighetti S., Tarenzi L., Rainero I., et al. Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain 2006, 121(1-2):133-144.
18. Benedetti F., Lanotte M., Lopiano L., Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007, 147(2):260-271.
19. Conti A.A. Nocebos and nocebo effects still exist though Hippocrates had recommended that patients would not be harmed. Med Hypotheses 2010, 74(1):207-208.
20. Kaptchuk T.J., Friedlander E., Kelley J.M., Sanchez M.N., Kokkotou E., Singer J.P., et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 2010, 5(12):e15591.